iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

Glenmark Pharmaceuticals Ltd Option Chain

Add as a Preferred Source on Google
2,279.1
(0.40%)
Aug 7, 2026|09:29:59 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.
Ol (lots)Call PriceStrike PricePut PriceOl (lots)
1,1250%₹395.7 0%1,880₹2 66.66%5,25040%
1,1250%₹361.85 0%1,920₹1.15 -58.92%12,750-26.08%
--1,940₹2.75 14.58%6,0000%
69,000-1.60%₹325.05 19.94%1,960₹2 -13.04%7,875-4.54%
58,875-1.87%₹283.8 7.21%2,000₹2.3 -49.45%84,0000%
34,1250%₹247.9 -4.74%2,020--
1,1250%₹238.55 0%2,040₹3 -31.03%16,8757.14%
1,5000%₹218.45 11.17%2,060₹3.5 -27.83%16,12543.33%
75,375-1.47%₹208.8 8.35%2,080₹4.6 -31.85%14,625-29.09%
14,2500%₹195.35 3.44%2,100₹5.35 -37.79%2,48,625-1.92%
2,2500%₹172.5 0%2,120₹7.1 -36.32%21,3751.78%
2,250100%₹169.7 19.25%2,140₹9.1 -35.46%64,12513.24%
88,8750%₹133 0%2,160₹11.2 -37.6%61,12522.55%
40,5000%₹132 18.38%2,180₹14.05 -33.72%63,750-16.25%
3,52,500-0.31%₹116.5 16.5%2,200₹18 -33.45%2,39,625-0.62%
71,250-3.06%₹100.05 17.36%2,220₹23.95 -28.72%73,50012%
1,20,375-3.02%₹86.25 15%2,240₹29.5 -29.08%99,3755.15%
2,31,750-0.64%₹73.25 16.08%2,260₹37.3 -26.71%1,17,000-1.88%
1,00,125-7.29%₹63.9 17.03%2,280₹46.05 -26.37%42,375197.36%
6,85,87544.01%₹53 14.84%2,300₹56.45 -22.61%2,05,87510.46%
67,12530.65%₹44.8 14.43%2,320--
72,0000%₹37 14.37%2,340--
52,50021.73%₹30.55 11.7%2,360--
3750%₹46.4 0%2,380--
2,91,375-2.99%₹21.5 9.13%2,400₹128 -9.85%44,2508.25%
31,87544.06%₹19 2.7%2,420₹210.35 0%7500%
81,75044.37%₹15.7 15.01%2,440--
60,37534.16%₹13.3 20.36%2,460₹258.4 0%3750%
3,06,000-28.73%₹9.3 2.19%2,500₹303.5 0%7,1250%
18,0000%₹7.35 0%2,520₹238 -21.21%25,8750%
99,00017.33%₹6.4 3.22%2,560--
47,625-5.92%₹4.55 -1.08%2,600--
29,25041.81%₹3.55 4.41%2,640₹362 -3.87%45,3750%

Glenmark Pharma.: Related NEWS

Glenmark Pharma Q3 FY26 Profit Rises 16% to ₹403.2 Crore

Revenue from North America increased 24% year on year to ₹970.6 crore, including income from the out licensing of ISB 2001.

31 Jan 2026|02:22 PM
Read More
Top Stocks for Today - 25th September 2025

Here are some of the stocks that may see significant price movement today: Polycab India, Tata Steel, Dalmia Bharat, etc.

25 Sep 2025|06:57 AM
Read More
Top Stocks for Today - 23rd September 2025

Here are some of the stocks that may see significant price movement today: Glenmark Pharma, Rail Vikas Nigam, Birla Corp, etc.

23 Sep 2025|07:01 AM
Read More
Glenmark subsidiary gets $700 Million in licensing deal; stock gains

At around 2.19 PM, Glenmark Pharma was trading 2.97% higher at ₹2,112.90 per piece, against the previous close of ₹2,051.90 on NSE.

9 Sep 2025|02:31 PM
Read More
Glenmark Pharma Q1 Net Profit Falls 86% YoY to ₹47 Crore

Operating performance was slightly weaker, with EBITDA dipping 1.4% to ₹580 crore from ₹588.2 crore.

18 Aug 2025|01:03 PM
Read More
Top Stocks for Today - 18th August 2025

Here are some of the stocks that may see significant price movement today: Glenmark Pharmaceuticals, Vedanta, Inox Wind, etc.

18 Aug 2025|08:14 AM
Read More
Glenmark Shares Surge 10% After AbbVie Inks Licensing Deal for ISB 2001

The compound is currently in Phase 1B clinical trials, being studied for multiple myeloma, a tough-to-treat form of blood cancer.

11 Jul 2025|09:48 AM
Read More
Top Stocks for Today - 11th July 2025

Here are some of the stocks that may see significant price movement today: Tata Consultancy Services, IREDA, Glenmark Pharma, etc.

11 Jul 2025|07:20 AM
Read More
Top Stocks for Today - 26th May 2025

Here are some of the stocks that may see significant price movement today: Glenmark Pharma, Ashok Leyland, NTPC, etc.

26 May 2025|06:34 AM
Read More
Glenmark Pharma’s cancer drug receive FDA ‘fast track’ status

ISB 2001 is a tri-specific antibody therapeutic for targeting BCMA and CD38 on myeloma cells, as well as CD3 on T cells.

6 May 2025|09:31 AM
Read More
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.